Prevention of adhesive capsulitis following pacemaker implantation: A randomized controlled study

2020 ◽  
Vol 43 (9) ◽  
pp. 1000-1003
Author(s):  
Mohammad Vahid Jorat ◽  
Seyedeh Mahdieh Namayandeh ◽  
Zahra Mehdipour Namdar ◽  
Amir Aslani
2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
K.J Choi ◽  
G.B Nam ◽  
J.H Zo ◽  
J.H Lee ◽  
M.S Cho ◽  
...  

Abstract Background Clinical outcomes after catheter ablation (CA) or pacemaker (PM) implantation for tachycardia-bradycardia syndrome (TBS) has not been well evaluated. Purpose This randomized controlled study compared the efficacy and safety outcomes of CA and PM implantation as an initial treatment for TBS with paroxysmal atrial fibrillation (AF). Methods A total of 70 patients with paroxysmal AF and TBS (mean 64 years, 64.3% male) underwent randomization, and received CA (CA group, n=35) or PM (PM group, n=35) as an initial treatment. The primary outcome was unexpected emergency room visit or hospitalization from any cardiovascular causes. Results The two groups were well-balanced with respect to the baseline characteristics except for difference in age (61.0±8.0 vs. 66.2±7.2, P=0.005). In the intention-to-treatment analysis, the rate of primary outcome was not significantly different between two groups at 2-years of follow-up (19.8% vs. 24.2%; HR 1.25, 95% CI 0.42–3.73, P=0.684). The same trend was noted when the result was adjusted for age (HR 1.16 95% CI 0.26–2.89, P=0.807). The rate of recurrent AF was significantly lower in CA group compared to PM group (24.0% vs. 100% at 2-yreas, P<0.001). Four patients (11.4%) in CA group finally received PM implantation after CA due to syncope. The rate of major or minor procedure related complications was not significantly different between two groups (14.3% vs. 14.3%, P>0.99). Conclusion In this randomized controlled study, CA was associated with a similar efficacy and safety with higher rate of sinus rhythm maintenance. CA could be considered a preferable treatment option over PM implantation in patients with paroxysmal AF and TBS. Funding Acknowledgement Type of funding source: None


2017 ◽  
pp. 79-88
Author(s):  
Hyoung Seop Kim

Background: Idiopathic adhesive capsulitis of the shoulder is a common disease, however, the optimal dosage of steroid in serial hydration has not been defined. Objectives: The aim of this study is to find the optimal dosage of triamcinolone acetonide with serial hydrodilatation for adhesive capsulitis of the shoulder. Study Design: Prospective, double blinded randomized controlled study. Setting: Secondary Training Hospital. Methods: Forty-two patients with adhesive capsulitis of the shoulder were randomly assigned to 20 mg or 40 mg intraarticular steroid injection with hydrodilatation groups using a double blind method. Data were assessed by visual analog scale (VAS) for pain, range of motion (ROM) questionnaire, shoulder pain questionnaire, and actual shoulder ROM (flexion, abduction, internal rotation, and external rotation). Data were collected before the injection and once every 4 weeks after the injection. Results: The baseline characteristics of the patients were not statistically different. Both groups were compared with their pretreated status in all measurements. (P < 0.05). There were no statistical differences between groups between the measurements. Limitations: The absence of a control group: a group that was administered hydrodilatation without steroid. Conclusion: We suggest 20 mg of steroid injection with serial hydrodilatation for adhesive capsulitis of the shoulder patients. Key words: Injections, intra-articular, triamcinolone acetonide, lidocaine, shoulder pain, shoulder joint, pain management, bursitis, pain measurement, adhesive capsulitis


2020 ◽  
Vol 35 (2) ◽  
pp. 212-219
Author(s):  
Rasmus Berggren ◽  
Jonna Nilsson ◽  
Yvonne Brehmer ◽  
Florian Schmiedek ◽  
Martin Lövdén

Sign in / Sign up

Export Citation Format

Share Document